, Insulin resistance and percent remaining pancreatic beta-cell function are unaffected, Endocrine Regulations, vol.50, issue.4, pp.183-193

K. Batumalaie, M. A. Amin, D. D. Murugan, M. Z. Sattar, and N. A. Abdullah, Withaferin A protects against palmitic acid-induced endothelial insulin resistance and dysfunction through suppression of oxidative stress and inflammation, Scientific Reports, vol.6, p.27236, 2016.

G. Boden, P. She, M. Mozzoli, P. Cheung, and K. Gumireddy,

N. Ruderman, Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver, Diabetes, vol.54, issue.12, pp.3458-3465, 2005.

A. M. Cheng, P. Handa, S. Tateya, J. Schwartz, C. Tang et al., Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts, PLoS ONE, vol.7, issue.3, p.33917, 2012.

B. Collier, L. A. Dossett, A. K. May, and J. J. Diaz, Glucose control and the inflammatory response, Nutrition in Clinical Practice, vol.23, issue.1, pp.3-15, 2008.

S. P. Cousin, S. R. Hugl, C. E. Wrede, H. Kajio, M. G. Myers et al., Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1, Endocrinology, vol.142, issue.1, pp.229-240, 2001.

N. Dimopoulos, M. Watson, K. Sakamoto, and H. S. Hundal, Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells, The Biochemical Journal, vol.399, issue.3, pp.473-481, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00478535

S. L. Doyle and L. A. Neill, Toll-like receptors: From the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity, Biochemical Pharmacology, vol.72, issue.9, pp.1102-1113, 2006.

H. Feng, R. Su, Y. Song, C. Wang, L. Lin et al., Positive correlation between enhanced expression of TLR4/MyD88/NF-kap-paB with insulin resistance in placentae of gestational diabetes mellitus, PLoS ONE, vol.11, issue.6, p.157185, 2016.

A. Gonzalez-periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong et al., Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: A role for resolvins and protectins, vol.23, pp.1946-1957, 2009.

C. J. Green, K. Macrae, S. Fogarty, D. G. Hardie, K. Sakamoto et al., Counter-modulation of fatty acid-induced proinflammatory nuclear factor kappaB signalling in rat skeletal muscle cells by AMP-activated protein kinase, The Biochemical Journal, vol.435, issue.2, pp.463-474, 2011.

D. Gupta, C. B. Krueger, and G. Lastra, Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction, Current Diabetes Reviews, vol.8, issue.2, pp.76-83, 2012.

L. P. Han, C. J. Li, B. Sun, Y. Xie, Y. Guan et al., Protective Effects of celastrol on diabetic liver injury via TLR4/MyD88/ NF-kappaB signaling pathway in Type 2 diabetic rats, Journal of Diabetes Research, p.2641248, 2016.

A. He, R. Ji, J. Shao, C. He, M. Jin et al., TLR4-MyD88-TRAF6-TAK1 complex-mediated NF-kappaB activation contribute to the antiinflammatory effect of V8 in LPS-induced human cervical cancer SiHa cells, Inflammation, vol.39, issue.1, pp.172-181, 2016.

M. Ishii, A. Maeda, S. Tani, and M. Akagawa, Palmitate induces insulin resistance in human HepG2 hepatocytes by enhancing ubiquitination and proteasomal degradation of key insulin signaling molecules, Archives of Biochemistry and Biophysics, vol.566, pp.26-35, 2015.

J. E. Kim, M. H. Lee, D. H. Nam, H. K. Song, Y. S. Kang et al., Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice, PLoS ONE, vol.8, issue.4, p.62068, 2013.

H. J. Kwak, H. E. Choi, J. Jang, S. K. Park, Y. A. Bae et al., Bortezomib attenuates palmitic acid-induced ER stress, inflammation and insulin resistance in myotubes via AMPK dependent mechanism, Cellular Signalling, vol.28, issue.8, pp.788-797, 2016.

J. Y. Lee, B. H. Lee, N. D. Kim, and J. Y. Lee, Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner, Journal of Ethnopharmacology, vol.172, pp.254-260, 2015.

J. H. Lee, T. H. Koo, H. Yoon, H. S. Jung, H. Z. Jin et al.,

J. J. Lee, Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid, Biochemical Pharmacology, vol.72, issue.10, pp.1311-1321, 2006.

H. Lei, F. Lu, H. Dong, L. Xu, J. Wang et al., Journal of Huazhong University of Science and Technology Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao Yi Xue Ying De Wen Ban, Huazhong Keji Daxue Xuebao Yixue Yingdewen Ban, vol.31, issue.2, pp.185-189, 2011.

G. Li, D. Liu, Y. Zhang, Y. Qian, H. Zhang et al.,

Y. Liu, Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblastlike synoviocyte invasion through suppression of TLR4/NF-kappaBmediated matrix metalloproteinase-9 expression, PLoS ONE, vol.8, issue.7, p.68905, 2013.

J. Liu, J. Lee, M. A. Salazar-hernandez, R. Mazitschek, and U. Ozcan, Treatment of obesity with celastrol, Cell, vol.161, issue.5, pp.999-1011, 2015.

M. Lotfy, J. Adeghate, H. Kalasz, J. Singh, and E. Adeghate, Chronic complications of diabetes mellitus: A mini review, Current Diabetes Reviews, vol.13, issue.1, pp.3-10, 2017.

X. Ma, L. Xu, A. T. Alberobello, O. Gavrilova, A. Bagattin et al.,

E. Mueller, Celastrol protects against obesity and metabolic dysfunction through activation of a HSF1-PGC1alpha transcriptional axis, Cell Metabolism, vol.22, issue.4, pp.695-708, 2015.

S. Nakamura, T. Takamura, N. Matsuzawa-nagata, H. Takayama, H. Misu et al., Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria, The Journal of Biological Chemistry, vol.284, issue.22, pp.14809-14818, 2009.

T. Paramo, T. J. Piggot, C. E. Bryant, and P. J. Bond, The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor, The Journal of Biological Chemistry, vol.288, issue.51, pp.36215-36225, 2013.

S. Park, H. J. Shin, M. Shah, H. Y. Cho, M. A. Anwar et al., TLR4/MD2 specific peptides stalled in vivo LPS-induced immune exacerbation, Biomaterials, vol.126, pp.49-60, 2017.

J. K. Ryu, S. J. Kim, S. H. Rah, J. I. Kang, H. E. Jung et al., Reconstruction of LPS transfer cascade reveals structural determinants within LBP, CD14, and TLR4-MD2 for efficient LPS recognition and transfer, Immunity, vol.46, issue.1, pp.38-50, 2017.

T. Sharifnia, J. Antoun, T. G. Verriere, G. Suarez, J. Wattacheril et al., Hepatic TLR4 signaling in obese NAFLD, American Journal of Physiology Gastrointestinal and Liver Physiology, vol.309, issue.4, pp.270-278, 2015.

M. She, H. Hou, Z. Wang, C. Zhang, M. Laudon et al., Melatonin rescues 3T3-L1 adipocytes from FFA-induced insulin resistance by inhibiting phosphorylation of IRS-1 on Ser307, Biochimie, vol.103, pp.126-130, 2014.

Y. F. Shen, X. Zhang, Y. Wang, F. F. Cao, G. Uzan et al., Celastrol targets IRAKs to block Toll-like receptor 4-mediated nuclear factor-kappaB activation, Journal of Integrative Medicine, vol.14, issue.3, pp.203-208, 2016.

Y. Shiba, Y. Yamasaki, M. Kubota, M. Matsuhisa, T. Tomita et al., Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model, Metabolism: Clinical and Experimental, vol.47, issue.8, pp.908-914, 1998.

J. Sun, J. Luo, Y. Ruan, L. Xiu, B. Fang et al., Free fatty acids activate renin-angiotensin system in 3T3-L1 Adipocytes through nuclear factor-kappa B pathway, Journal of Diabetes Research, p.1587594, 2016.

T. T. Tran, B. G. Postal, S. Demignot, A. Ribeiro, C. Osinski et al., Short term palmitate supply impairs intestinal insulin signaling via ceramide production, The Journal of Biological Chemistry, vol.291, issue.31, pp.16328-16338, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01369518

M. Van-beek, K. I. Oravecz-wilson, P. C. Delekta, S. Gu, X. Li et al.,

P. C. Lucas, Bcl10 links saturated fat overnutrition with hepatocellular NF-kB activation and insulin resistance, Cell Reports, vol.1, issue.5, pp.444-452, 2012.

K. Vogt, M. Warrelmann, and H. Hahn, Effect of bismuth subcarbonate against Campylobacter pylori: Do citrate ions improve antibacterial activity? Zentralblatt Fur Bakteriologie, International Journal of Medical Microbiology, vol.273, issue.1, pp.33-35, 1990.

C. M. Volpe and J. A. Nogueira-machado, The dual role of free fatty acid signaling in inflammation and therapeutics, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, vol.7, issue.3, pp.189-197, 2013.

Y. Wang, Y. Qian, Q. Fang, P. Zhong, W. Li et al.,

G. Liang, Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2, Nature Communications, vol.8, p.13997, 2017.

H. Wang, Q. Zhang, Y. Chai, Y. Liu, F. Li et al., 1,25 (OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats, The Journal of Endocrinological Investigation, vol.38, issue.10, pp.1083-1091, 2015.

W. Zhang, Z. Tang, X. Zhu, N. Xia, Y. Zhao et al.,

C. Wang, TRAF1 knockdown alleviates palmitate-induced insulin resistance in HepG2 cells through NF-kappaB pathway, Biochemical and Biophysical Research Communications, vol.467, issue.3, pp.527-533, 2015.

J. Zhang, Y. Zhao, C. Xu, Y. Hong, H. Lu et al., Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study, Scientific Reports, vol.4, p.5832, 2014.

X. Zhang, Y. Wang, and H. Ge, How to cite this article

, Celastrol reverses palmitic acid (PA)-caused TLR4-MD2 activation-dependent insulin resistance via disrupting MD2-related cellular binding to PA, J Cell Physiol, pp.1-11, 2018.

, , vol.233, pp.6814-6824, 2018.